arrow
A

Andrei S. Gudymo

vector
H指数:10
被引数:374

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Intranasal Immunization with Recombinant Hemagglutinin of Influenza A/H5 Virus Complexed with Novochizol Induces Virus-Neutralizing Antibodies and Protects Animals from Lethal Viral Challenge

通过Novochizol复合的重组流感A/H5病毒血凝素经鼻免疫可诱导中和抗体并保护动物免受致死病毒攻击

2026-05-290
OA
Immunogenic and Protective Properties of mRNA Vaccine Encoding Hemagglutinin of Avian Influenza A-H5N8 Virus, Delivered by Lipid Nanoparticles and Needle-Free Jet Injection

编码禽流感A-H5N8病毒血凝素并由脂质纳米颗粒递送和针头自由喷射注射的mRNA疫苗的免疫原性和保护性特征

2025-08-220
PRE
Genetic diversity of A(H5N1) avian influenza viruses isolated from birds and seals in Russia in 2023

2023年在俄罗斯从鸟类和海豹中分离的A(H5N1)禽流感病毒的遗传多样性

2025-05-140
OA
Dose-Dependent Effect of DNA Vaccine pVAX-H5 Encoding a Modified Hemagglutinin of Influenza A (H5N8) and Its Cross-Reactivity Against A (H5N1) Influenza Viruses of Clade 2.3.4.4b
2025-02-270
OAAI
Characterization of H5N1 avian influenza virus isolated from bird in Russia with the E627K mutation in the PB2 protein
2024-11-031
OAAI
DNA Vaccine Encoding a Modified Hemagglutinin Trimer of Avian Influenza A Virus H5N8 Protects Mice from Viral Challenge
2024-05-140
OAAI
Immunogenic and Protective Properties of Recombinant Hemagglutinin of Influenza A (H5N8) Virus

甲型 (H5N8) 流感病毒重组血凝素的免疫原性和保护性

2024-01-292
OAAI
Assessment of Safety and Prophylactic Efficacy of the EpiVacCorona Peptide Vaccine for COVID-19 Prevention (Phase III)

EpiVacCorona肽疫苗预防新型冠状病毒肺炎的安全性和预防效果评估(III期)

2023-05-189
OAAI
Re-Emergence of Circulation of Seasonal Influenza during COVID-19 Pandemic in Russia and Receptor Specificity of New and Dominant Clade 3C.2a1b.2a.2 A(H3N2) Viruses in 2021-2022
2022-11-217
OAAI
The Tissue Distribution of SARS-CoV-2 in Transgenic Mice With Inducible Ubiquitous Expression of hACE2
2022-01-187
OAAI